118 HR 3884 IH: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 U.S. House of Representatives 2023-06-07 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 3884IN THE HOUSE OF REPRESENTATIVESJune 7, 2023Mr. Burgess (for himself, Mr. Davis of Illinois, and Mr. Carter of Georgia) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.

1.

Short title

This Act may be cited as the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023.

2.

Reauthorization of sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment

Section 1106(b)(6) of the Public Health Service Act (42 U.S.C. 300b–5(b)(6)) is amended by striking 2019 through 2023 and inserting 2024 through 2028.